Metrions High-throughput Screening Process

Nav1.8 Assays for Pain Drug Discovery | Insights from Dr Eddy Stevens, CSO

Manual patch clamp expertise working with a variety of different ion channel targets

Automated patch clamp: Seal enhancers on the Qube 384: An alternative to F

Metrion success expressing targets that are hard to express

Introduction to ion channel screening at Metrion

Introduction to Metrion, leaders in ion channel, cardiac safety and neuroscience screening

High-Throughput Automated Electrophysiology Assay for Human Nav1.9 Inhibitor Screening

Neuroscience preclinical drug discovery services from Metrion

Breaking New Ground in Chronic Pain Relief_ Advancements in Drug Discovery for Trigeminal Neuralgia

Recent Progress Towards a Potential Treatment for KCNC1-related Disorders

In Vitro Assessment of Cardiac Risk in Drug Discovery

Studying ion channels on the lysosomal membrane

Effect of hERG blocker ondansetron on action potential waveform in human stem cell cardiomyocytes

Demonstration of Endo-Lysosomal Patch Clamp Technique

Metrion's Neuroscience Services

High Throughput Screening at Metrion Biosciences

Cardiac Safety Services

Metrion Webinar – Dr. Manoj Patel

Metrion Biosciences laboratory Tour

Metrion Webinar - Dr Kris Kahlig

Metrion Webinar - Dr Greg Carr - LIBD

Metrion Webinar - Presented by Professor David Sheppard

Professor Stephen Tucker presents Metrion's second webinar

Metrion Newsletter Summary June 2021

Metrion Biosciences CEO Overview Presentation

Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays

Targeting ion channels in drug discovery